1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-3.66%
Both yoy net incomes decline, with GNPX at -36.01%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
13.04%
Some D&A expansion while GNPX is negative at -33.91%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
100.00%
Deferred tax of 100.00% while GNPX is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
1.43%
SBC growth while GNPX is negative at -13.92%. John Neff would see competitor possibly controlling share issuance more tightly.
-401.62%
Negative yoy working capital usage while GNPX is 49.23%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative yoy AP while GNPX is 834.33%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-97.99%
Both reduce yoy usage, with GNPX at -196.47%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-100.00%
Both negative yoy, with GNPX at -46403300.00%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-93.84%
Both yoy CFO lines are negative, with GNPX at -51.15%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-375.00%
Negative yoy CapEx while GNPX is 1.86%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-375.00%
Both yoy lines negative, with GNPX at -199.72%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-84.27%
Negative yoy issuance while GNPX is 87245.46%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.